...
首页> 外文期刊>International journal of antimicrobial agents >Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis
【24h】

Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis

机译:抗粘连和抗增殖的三乙酸纤维素膜可预防与表皮葡萄球菌相关的以生物材料为中心的感染

获取原文
获取原文并翻译 | 示例

摘要

The initial step in preventing biomaterial-associated infections consists of preventing bacterial adhesion to the device surface. One possible approach is the design of antibiotic-releasing biomaterials. Cellulose triacetate (CTA) membranes with the antibiotic imipenem (IPM) entrapped (CTA-IPM) were prepared. The material was characterised in terms of surface morphology by scanning electron microscopy, surface free energy of interaction and X-ray photoelectron spectroscopy (XPS). Antibiotic release studies were also performed. In vitro adhesion of Staphylococcus epidermidis RP62A to CTA-IPM was investigated using a modified microtitre plate assay, and the antibacterial activity of the CTA-IPM membrane was assessed by a modified Kirby-Bauer test, which showed effective entrapment of the antibiotic as confirmed by XPS and hydrophilicity assays. Release studies showed that this drug-polymer conjugate serves as an adequate reservoir for sustained release of IPM over a period of 71 h at an effective bacteriostatic concentration. Moreover, bacterial adhesion tests showed a statistically significant decrease in the adhesion of S. epidermidis RP62A to CTA-IPM compared with its adhesion to CTA alone. The present innovative approach is capable of providing a membrane with anti-adhesive and antiproliferative properties, thus encouraging in vivo studies to provide a better simulation of the clinical situation.
机译:防止生物材料相关感染的第一步是防止细菌粘附到设备表面。一种可能的方法是设计释放抗生素的生物材料。制备了包裹了抗生素亚胺培南(IPM)的纤维素三乙酸酯(CTA)膜(CTA-IPM)。通过扫描电子显微镜,相互作用的表面自由能和X射线光电子能谱(XPS)对材料进行了表面形貌表征。还进行了抗生素释放研究。使用改良的微量滴定板法研究了表皮葡萄球菌RP62A在体外对CTA-IPM的粘附性,并通过改良的Kirby-Bauer试验评估了CTA-IPM膜的抗菌活性,该试验表明有效的包埋抗生素已通过XPS和亲水性测定。释放研究表明,这种药物-聚合物共轭物可在有效抑菌浓度下充当IPM在71小时内持续释放的适当储库。此外,细菌粘附测试显示,与单独的CTA粘附相比,表皮葡萄球菌RP62A对CTA-IPM的粘附在统计学上显着降低。本发明的创新方法能够提供具有抗粘附和抗增殖特性的膜,从而鼓励体内研究以提供对临床情况的更好模拟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号